New SEC Learning Blocks, Life Sciences Deep Dive, John Hustonisms, NEW Deadline Announced & More!

The SEC’s Capital Raising Building Blocks break down capital raising fundamentals into plain language.

They’ve just released four new topics:

The Best Time to Be a Life Sciences Investor is Now

Tuesday, May 16 – 5:00p

Description: While COVID-19 severely impacted global health and economics, it also drove positive change in the bloated technology resistant US healthcare system. When physicians were no longer able to see patients or provide healthcare, the system had no choice but to open up to change. The result is the best opportunity for healthcare startups in our lifetime to drive meaningful change. In return, innovative technology and business models must maintain or improve patient outcomes while reducing costs. Learn the dynamics favoring our sector in today’s economy.

Speakers: Allan May, Life Sciences Angels, Martin Gershon, Harvard Business School Alumni Angels, Endeavor

Deep Dive Into Investing in Digital Health

Wednesday, May 17 – 2:30p

Description: The investment considerations that impact Digital Health are different than those for traditional sectors in Medtech/biotech. Digital health includes AI and Data and is much more than software/software and includes data analytics, prediction and prognostics. Big Tech has invested $100B in the last decade with over 200 investments by Google alone. Big Tech and Big Pharma have escalated their interest in digital partnering that can provide different solutions to address the needs of patients, hospitals and payers. Game on!

Speakers: Martin Gershon, Harvard Business School Alumni Angels, Endeavor Funds, David Perez, New Mexico Angels

Comparing Risk and Returns in MedTech, BioTech/Genomics and Diagnostics

Session #3 – Wednesday, May 18 – 3:30p

Description: This session will dig into the current landscape of the largest sectors within life sciences. While reimbursement is the 800lb gorilla in medical devices, in biotech and therapeutics it is not even a factor. Biotech has the highest value exits but also requires the most cash. Diagnostics and genomics tools are on fire but Point of Care diagnostics continue to disappoint. Learn how the pros assess risks and challenges in each of the core life science sectors.

Speakers: Allan May, Life Sciences Angels, Carolyn Myers, BIOESEMBLE Bio/tx, Yaniv Sanov, MABA Bio Tx

Understanding our ecosystem drives the Angel Capital Association and how we support our members as the steward of the angel investment community.

We have extended the deadline for the 2023 ACA Investor Sentiment Survey! In addition to landscape awareness, this annual survey, which is a complement to ACA’s Angel Funders Reportcollection, serves as a benchmark for the growth and character of angel investing.

Please contribute to this important work by completing the survey today!

Learn, IN PERSON, From Some of the Greatest Minds in Angel Investing

Angel Investing Basics:

Angel Investing Deeper Dive:

Valuation Course: Negotiating the current valuation of seed-stage startups at the time of investment is a critical component of angel term sheets. Getting valuation right establishes a fair percentage of ownership for both investors and entrepreneurs and optimizes returns for investing angels. This course introduces participants to startup valuation and demonstrates multiple valuation methodologies. In addition to valuation methods, the lead instructor will provide insights into the impact of stage of development, geographic location, business sector and the global economy on startup valuation. The program leaves attendees with an exercise to help hone their newly acquired valuation skills by using these valuation methods in appraising a case study company.

Thank You to Our ACA Annual Partners

If you’re interested in sponsoring ACA annually or for the Summit of Angel Investing, please reach out to Partnerships Director Damien Delgado.